Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter

ACS Appl Mater Interfaces. 2016 Apr 13;8(14):9014-21. doi: 10.1021/acsami.6b02662. Epub 2016 Apr 1.

Abstract

MicroRNAs (miRNAs) are a class of post-transcriptional gene regulators involved in various physiological processes including carcinogenesis, and they have emerged as potential targets for tumor theranostics. However, the employment of antisense oligonucleotides, termed anti-miRs, for antagonizing miRNA functions in vivo has largely been impeded by a lack of effective delivery carriers. Here, we describe the development of polyamidoamine (PAMAM) dendrimer and polyethylene glycol (PEG)-functionalized nanographene oxide (NGO) conjugate (NGO-PEG-dendrimer) for the efficient delivery of anti-miR-21 into non-small-cell lung cancer cells. To monitor the delivery of anti-miR-21 into cells and tumors, we also constructed an activatable luciferase reporter (Fluc-3xPS) containing three perfectly complementary sequences against miR-21 in the 3' untranslated region (UTR) of the reporter. Compared with bare dendrimer and Lipofectamine 2000 (Lipo2000), NGO-PEG-dendrimer showed considerably lower cytotoxicity and higher transfection efficiency. As demonstrated by in vitro bioluminescence imaging and Western blotting assays, NGO-PEG-dendrimer effectively delivered anti-miR-21 into the cytoplasm and resulted in the upregulation of luciferase intensity and PTEN target protein expression in a dose-dependent manner. Moreover, transfection with anti-miR-21 by NGO-PEG-dendrimer led to stronger inhibition of cell migration and invasion than did bare dendrimer or Lipo2000 transfection. The intravenous delivery of anti-miR-21 via NGO-PEG-dendrimer induced a significant increase in the bioluminescence signal within the Fluc-3xPS reporter-transplanted tumor areas. These results suggest that NGO-PEG-dendrimer could be an efficient and a potential nanocarrier for delivering RNA oligonucleotides. In addition, the strategy of combining NGO-PEG-dendrimer with an activatable luciferase reporter allows the image-guided monitoring of the delivery process, which can provide insights into the RNA-based cancer treatments.

Keywords: bioluminescence imaging; dendrimer; graphene oxide; luciferase reporter; miRNA delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Dendrimers / administration & dosage
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Transfer Techniques
  • Graphite / administration & dosage*
  • Graphite / chemistry
  • Humans
  • Lipids / therapeutic use
  • Mice
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / genetics*
  • Molecular Imaging
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Oligonucleotides, Antisense / administration & dosage*
  • Oligonucleotides, Antisense / genetics
  • Oligonucleotides, Antisense / therapeutic use
  • PTEN Phosphohydrolase / biosynthesis
  • Polyethylene Glycols / administration & dosage
  • Xenograft Model Antitumor Assays

Substances

  • Dendrimers
  • Lipids
  • Lipofectamine
  • MIRN21 microRNA, human
  • MicroRNAs
  • Oligonucleotides, Antisense
  • PAMAM Starburst
  • Polyethylene Glycols
  • Graphite
  • PTEN Phosphohydrolase
  • PTEN protein, human